Germain RN: T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol. 2002, 2: 309-322.
CAS
PubMed
Google Scholar
Spits H: Development of alphabeta T cells in the human thymus. Nat Rev Immunol. 2002, 2: 760-772.
CAS
PubMed
Google Scholar
Weiss A: T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell. 1993, 73: 209-212.
CAS
PubMed
Google Scholar
Chan AC, Iwashima M, Turck CW, Weiss A: ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell. 1992, 71: 649-662.
CAS
PubMed
Google Scholar
Jacobs MR, Haynes BF: Increase in TCR gamma delta T lymphocytes in synovia from rheumatoid arthritis patients with active synovitis. J Clin Immunol. 1992, 12: 130-138.
CAS
PubMed
Google Scholar
Olive C, Gatenby PA, Serjeantson SW: Evidence for oligoclonality of T cell receptor delta chain transcripts expressed in rheumatoid arthritis patients. Eur J Immunol. 1992, 22: 2587-2593.
CAS
PubMed
Google Scholar
June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today. 1994, 15: 321-331.
CAS
PubMed
Google Scholar
Lindsten T, June CH, Ledbetter JA, Stella G, Thompson CB: Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science. 1989, 244: 339-343.
CAS
Google Scholar
Fraser JD, Irving BA, Crabtree GR, Weiss A: Regulation of inter-leukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science. 1991, 251: 313-316.
CAS
PubMed
Google Scholar
Li-Weber M, Giasi M, Krammer PH: Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J Biol Chem. 1998, 273: 32460-32466.
CAS
PubMed
Google Scholar
Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, Thompson CB: CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 1995, 3: 87-98.
CAS
PubMed
Google Scholar
Alegre ML, Noel PJ, Eisfelder BJ, Chuang E, Clark MR, Reiner SL, Thompson CB: Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol. 1996, 157: 4762-4770.
CAS
PubMed
Google Scholar
Cerdan C, Martin Y, Courcoul M, Brailly H, Mawas C, Birg F, Olive D: Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol. 1992, 149: 2255-2261.
CAS
PubMed
Google Scholar
Yin D, Zhang L, Wang R, Radvanyi L, Haudenschild C, Fang Q, Kehry MR, Shi Y: Ligation of CD28 In vivo induces CD40 ligand expression and promotes B cell survival. J Immunol. 1999, 163: 4328-4334.
CAS
PubMed
Google Scholar
Arai K, Yamamura S, Seki S, Hanyu T, Takahashi HE, Abo T: Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory role. Clin Exp Immunol. 1998, 111: 345-352.
PubMed Central
CAS
PubMed
Google Scholar
Wang EC, Lawson TM, Vedhara K, Moss PA, Lehner PJ, Borysiewicz LK: CD8high+ (CD57+) T cells in patients with rheumatoid arthritis. Arthritis Rheum. 1997, 40: 237-248.
CAS
PubMed
Google Scholar
Hingorani R, Monteiro J, Furie R, Chartash E, Navarrete C, Pergolizzi R, Gregersen PK: Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. J Immunol. 1996, 156: 852-858.
CAS
PubMed
Google Scholar
Fazou C, Yang H, McMichael AJ, Callan MF: Epitope specificity of clonally expanded populations of CD8+ T cells found within the joints of patients with inflammatory arthritis. Arthritis Rheum. 2001, 44: 2038-2045.
CAS
PubMed
Google Scholar
Berner B, Akca D, Jung T, Muller GA, Reuss-Borst MA: Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol. 2000, 27: 1128-1135.
CAS
PubMed
Google Scholar
Kang YM, Zhang X, Wagner UG, Yang H, Beckenbaugh RD, Kurtin PJ, Goronzy JJ, Weyand CM: CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med. 2002, 195: 1325-1336.
PubMed Central
CAS
PubMed
Google Scholar
Wagner UG, Kurtin PJ, Wahner A, Brackertz M, Berry DJ, Goronzy JJ, Weyand CM: The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol. 1998, 161: 6390-6397.
CAS
PubMed
Google Scholar
Ehinger M, Vestberg M, Johansson AC, Johannesson M, Svens-son A, Holmdahl R: Influence of CD4 or CD8 deficiency on collagen-induced arthritis. Immunology. 2001, 103: 291-300.
PubMed Central
CAS
PubMed
Google Scholar
Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, David CS: CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol. 2002, 168: 5867-5875.
CAS
PubMed
Google Scholar
Van Boxel JA, Paget SA: Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med. 1975, 293: 517-520.
CAS
PubMed
Google Scholar
Banerjee S, Webber C, Poole AR: The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol. 1992, 144: 347-357.
CAS
PubMed
Google Scholar
Breedveld FC, Dynesius-Trentham R, de Sousa M, Trentham DE: Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by iron. Cell Immunol. 1989, 121: 1-12.
CAS
PubMed
Google Scholar
Panayi GS, Tugwell P: The use of cyclosporin A in rheumatoid arthritis: conclusions of an international review. Br J Rheumatol. 1994, 33: 967-969.
CAS
PubMed
Google Scholar
Paulus HE, Machleder HI, Levine S, Yu DT, MacDonald NS: Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum. 1977, 20: 1249-1262.
CAS
PubMed
Google Scholar
Strober S, Tanay A, Field E, Hoppe RT, Calin A, Engleman EG, Kotzin B, Brown BW, Kaplan HS: Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial. Ann Intern Med. 1985, 102: 441-449.
CAS
PubMed
Google Scholar
Calin A, Elswood J, Klouda PT: Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. Arthritis Rheum. 1989, 32: 1221-1225.
CAS
PubMed
Google Scholar
Winchester R: The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol. 1994, 56: 389-466.
CAS
PubMed
Google Scholar
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986, 136: 2348-2357.
CAS
PubMed
Google Scholar
Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature. 1996, 383: 787-793.
CAS
PubMed
Google Scholar
Rocken M, Saurat JH, Hauser C: A common precursor for CD4+ T cells producing IL-2 or IL-4. J Immunol. 1992, 148: 1031-1036.
CAS
PubMed
Google Scholar
Da Silva JA, Spector TD: The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol. 1992, 11: 189-194.
CAS
PubMed
Google Scholar
Mishan-Eisenberg G, Borovsky Z, Weber MC, Gazit R, Tykocinski ML, Rachmilewitz J: Differential regulation of Th1/Th2 cytokine responses by placental protein 14. J Immunol. 2004, 173: 5524-5530.
CAS
PubMed
Google Scholar
Verhoef CM, van Roon JA, Vianen ME, Bruijnzeel-Koomen CA, Lafeber FP, Bijlsma JW: Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance. Ann Rheum Dis. 1998, 57: 275-280.
PubMed Central
CAS
PubMed
Google Scholar
Ioannou Y, Isenberg DA: Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum. 2000, 43: 1431-1442.
CAS
PubMed
Google Scholar
Peeva E, Fishman AD, Goddard G, Wadler S, Barland P: Rheumatoid arthritis exacerbation caused by exogenous interleukin-12. Arthritis Rheum. 2000, 43: 461-463.
CAS
PubMed
Google Scholar
Miltenburg AM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC: T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol. 1992, 35: 603-610.
CAS
PubMed
Google Scholar
Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Forre O, Natvig JB: Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0) cytokine patterns. Scand J Immunol. 1993, 38: 75-82.
CAS
PubMed
Google Scholar
Kusaba M, Honda J, Fukuda T, Oizumi K: Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol. 1998, 25: 1466-1471.
CAS
PubMed
Google Scholar
Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, Salvador G, Munoz-Gomez J: Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis. 2000, 59: 263-268.
PubMed Central
CAS
PubMed
Google Scholar
Davis LS, Cush JJ, Schulze-Koops H, Lipsky PE: Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells. Arthritis Res. 2001, 3: 54-64.
PubMed Central
CAS
PubMed
Google Scholar
van der Graaff WL, Prins AP, Niers TM, Dijkmans BA, van Lier RA: Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology. 1999, 38: 214-220.
CAS
PubMed
Google Scholar
Miyata M, Ohira H, Sasajima T, Suzuki S, Ito M, Sato Y, Kasukawa R: Significance of low mRNA levels of interleukin-4 and -10 in mononuclear cells of the synovial fluid of patients with rheumatoid arthritis. Clin Rheumatol. 2000, 19: 365-370.
CAS
PubMed
Google Scholar
Schulze-Koops H, Lipsky PE, Kavanaugh AF, Davis LS: Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis: modulation by treatment with anti-ICAM-1 correlates with clinical benefit. J Immunol. 1995, 155: 5029-5037.
CAS
PubMed
Google Scholar
Kanik KS, Hagiwara E, Yarboro CH, Schumacher HR, Wilder RL, Klinman DM: Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. J Rheumatol. 1998, 25: 16-22.
CAS
PubMed
Google Scholar
Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004, 200: 277-285.
PubMed Central
CAS
PubMed
Google Scholar
Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C: Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003, 33: 215-23.
CAS
PubMed
Google Scholar
Weiner HL: Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 2001, 3: 947-954.
CAS
PubMed
Google Scholar
Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmstrom V: CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther. 2004, 6: R335-R346.
PubMed Central
CAS
PubMed
Google Scholar
Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997, 389: 737-742.
CAS
PubMed
Google Scholar
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995, 155: 1151-1164.
CAS
PubMed
Google Scholar
McHugh RS, Shevach EM: Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol. 2002, 168: 5979-5983.
CAS
PubMed
Google Scholar
Mottet C, Uhlig HH, Powrie F: Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003, 170: 3939-3943.
CAS
PubMed
Google Scholar
Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN: Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol. 2001, 31: 1122-1131.
CAS
PubMed
Google Scholar
Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH: Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001, 193: 1285-1294.
PubMed Central
CAS
PubMed
Google Scholar
Levings MK, Sangregorio R, Roncarolo MG: Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med. 2001, 193: 1295-1302.
PubMed Central
CAS
PubMed
Google Scholar
Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G: Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med. 2001, 193: 1303-1310.
PubMed Central
CAS
PubMed
Google Scholar
Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001, 167: 1245-1253.
CAS
PubMed
Google Scholar
Stephens LA, Mottet C, Mason D, Powrie F: Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol. 2001, 31: 1247-1254.
CAS
PubMed
Google Scholar
Annunziato F, Cosmi L, Liotta F, Lazzeri E, Manetti R, Vanini V, Romagnani P, Maggi E, Romagnani S: Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymo-cytes. J Exp Med. 2002, 196: 379-387.
PubMed Central
CAS
PubMed
Google Scholar
Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH: Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002, 168: 4272-4276.
CAS
PubMed
Google Scholar
Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998, 188: 287-296.
PubMed Central
CAS
PubMed
Google Scholar
Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S: Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2000, 192: 303-310.
PubMed Central
CAS
PubMed
Google Scholar
McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, Byrne MC: CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glu-cocorticoid-induced TNF receptor. Immunity. 2002, 16: 311-323.
CAS
PubMed
Google Scholar
Hori S, Takahashi T, Sakaguchi S: Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol. 2003, 81: 331-371.
CAS
PubMed
Google Scholar
Piccirillo CA, Shevach EM: Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol. 2004, 16: 81-88.
CAS
PubMed
Google Scholar
van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS: CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 2004, 50: 2775-2785.
PubMed
Google Scholar
van Amelsfort JM, Noordegraaf M, Bijlsma JWJ, Taams LS, Lafeber FPJG: Influence of the inflammatory milieu on the suppressive function of CD4+CD25+ T cells in rheumatoid arthritis. Arthritis Rheum. 2004, 50: S526-
Google Scholar
Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of TH1 CD4+ T cells through IL-12 produced by Listeria -induced macrophages. Science. 1993, 260: 547-549.
CAS
PubMed
Google Scholar
Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, Van Eden W, Van Der Zee R, Biedermann T, Prinz J, Mack M, et al: Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med. 2003, 9: 40-46.
CAS
PubMed
Google Scholar
Horsfall AC, Butler DM, Marinova L, Warden PJ, Williams RO, Maini RN, Feldmann M: Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol. 1997, 159: 5687-5696.
CAS
PubMed
Google Scholar
Miossec P, Chomarat P, Dechanet J, Moreau JF, Roux JP, Delmas P, Banchereau J: Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum. 1994, 37: 1715-1722.
CAS
PubMed
Google Scholar
Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J: Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum. 1992, 35: 874-883.
CAS
PubMed
Google Scholar
Hidaka T, Kitani A, Hara M, Harigai M, Suzuki K, Kawaguchi Y, Ishizuka T, Kawagoe M, Nakamura H: IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis. Clin Exp Immunol. 1992, 89: 223-229.
PubMed Central
CAS
PubMed
Google Scholar
Skapenko A, Wendler J, Lipsky PE, Kalden JR, Schulze-Koops H: Altered memory T cell differentiation in patients with early rheumatoid arthritis. J Immunol. 1999, 163: 491-499.
CAS
PubMed
Google Scholar
Schulze-Koops H, Lipsky PE: Anti-CD4 monoclonal antibody therapy in human autoimmune diseases. Curr Dir Autoimmun. 2000, 2: 24-49.
CAS
PubMed
Google Scholar
Schulze-Koops H, Kalden JR: Targeting T cells in rheumatic diseases. Biological Therapy in Rheumatology. Edited by: Smolen JS, Lipsky PE. 2003, London: Martin Dunitz Publishers, 3-24.
Google Scholar
Panayi GS: Targeting of cells involved in the pathogenesis of rheumatoid arthritis. Rheumatology. 1999, 38 (Suppl 2): 8-10.
PubMed
Google Scholar
Yocum DE: T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis. Semin Arthritis Rheum. 1999, 29: 27-35.
CAS
PubMed
Google Scholar
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenende Roo CJ, Heinegard D, van den Berg WB: Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res. 1999, 1: 81-91.
PubMed Central
CAS
PubMed
Google Scholar
Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D, Fournier C: Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete inter-leukin-13. Eur J Immunol. 1996, 26: 2399-2403.
CAS
PubMed
Google Scholar
Bruneau JM, Yea CM, Spinella-Jaegle S, Fudali C, Woodward K, Robson PA, Sautes C, Westwood R, Kuo EA, Williamson RA, Ruuth E: Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 the active metabolite of leflunomide. Biochem J. 1726, 336: 299-303.
Google Scholar
Dimitrova P, Skapenko A, Herrmann ML, Schleyerbach R, Kalden JR, Schulze-Koops H: Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation. J Immunol. 2002, 169: 3392-3399.
CAS
PubMed
Google Scholar
Kang BY, Chung SW, Im SY, Choe YK, Kim TS: Sulfasalazine prevents T-helper 1 immune response by suppressing interleukin-12 production in macrophages. Immunology. 1999, 98: 98-103.
PubMed Central
CAS
PubMed
Google Scholar
Constantin A, Loubet-Lescoulie P, Lambert N, Yassine-Diab B, Abbal M, Mazieres B, de Preval C, Cantagrel A: Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased inter-leukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis Rheum. 1998, 41: 48-57.
CAS
PubMed
Google Scholar
de Groot K, Gross WL: Wegener's granulomatosis: disease course, assessment of activity and extent and treatment. Lupus. 1998, 7: 285-291.
CAS
PubMed
Google Scholar
Morinobu A, Wang Z, Kumagai S: Bucillamine suppresses human Th1 cell development by a hydrogen peroxide-independent mechanism. J Rheumatol. 2000, 27: 851-858.
CAS
PubMed
Google Scholar
Almawi WY, Melemedjian OK, Rieder MJ: An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile. Clin Transplant. 1999, 13: 365-374.
CAS
PubMed
Google Scholar
Ranges GE, Sriram S, Cooper SM: Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med. 1985, 162: 1105-1110.
CAS
PubMed
Google Scholar
Waldor MK, Sriram S, Hardy R, Herzenberg LA, Lanier L, Lim M, Steinman L: Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science. 1985, 227: 415-417.
CAS
PubMed
Google Scholar
Wofsy D, Seaman WE: Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J Immunol. 1987, 138: 3247-3253.
CAS
PubMed
Google Scholar
Schulze-Koops H, Davis LS, Haverty TP, Wacholtz MC, Lipsky PE: Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4. J Rheumatol. 1998, 25: 2065-2076.
CAS
PubMed
Google Scholar
Ellis CN, Krueger GG: Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med. 2001, 345: 248-255.
CAS
PubMed
Google Scholar
Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, Menter A, Lowe NJ, Krueger G, Brown MJ, et al: CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest. 1999, 103: 1243-1252.
PubMed Central
CAS
PubMed
Google Scholar
Moreland LW, Alten R, Van Den Bosch F, Appelboom T, Leon M, Emery P, Cohen S, Luggen M, Shergy W, Nuamah I, et al: Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. Arthritis Rheum. 2002, 46: 1470-1479.
CAS
PubMed
Google Scholar
Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, Russell A, Dougados M, Emery P, Nuamah IF, et al: Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med. 2003, 349: 1907-1915.
CAS
PubMed
Google Scholar
Kavanaugh AF, Lightfoot E, Lipsky PE, Oppenheimer-Marks N: The role of CD11/CD18 in adhesion and transendothelial migration of T cells: analysis utilizing CD18 deficient T cell clones. J Immunol. 1991, 146: 4149-4156.
CAS
PubMed
Google Scholar
Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE: Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 1994, 37: 992-999.
CAS
PubMed
Google Scholar